近親静脈血栓症の長期的な治療のための代替アプローチの費用対効果分析
JAMA
|July 13, 1984
まとめ
ウォルファリンナトリウムは,より濃度の低い経口抗凝固剤であり,近接静脈血栓症に対する最も費用対効果の高い長期的な治療法です. このアプローチは,最近の臨床試験データに基づいて,ほとんどの患者に推奨されます.
科学分野:
- 薬学経済学 薬学経済学
- 血管医学 血管医学とは
- 臨床試験分析 臨床試験分析について
背景:
- 近親静脈血栓症 (PVT) の管理には,長期の抗凝固剤療法が含まれています.
- 様々なPVT治療の有効性と安全性は,十分に文書化されています.
- 長期的なPVT療法の費用対効果は,まだ十分に研究されていない.
研究 の 目的:
- PVTの異なる長期抗凝固剤治療の費用対効果の分析を実施する.
- 経済的価値に基づいて代替治療戦略をランク付けする.
- 大多数のPVT患者にとって最も費用対効果の高いアプローチを特定する.
主な方法:
- 費用対効果の分析が行われました.
- 抗凝固剤療法に関するランダム化試験のデータを利用した.
- 代替的な長期治療のアプローチの順位を付けました.
主要な成果:
- ウォルファリンナトリウムによるより低濃度の経口抗凝固剤治療は,最も費用対効果の高い選択肢として浮上しました.
- ウォルファリンナトリウムは,他の長期抗凝固剤と比較して優れた経済的価値を示しました.
- この分析は,PVTのほとんどの患者にとってウォルファリンナトリウムが好ましい選択であることを支持しています.
結論:
- ワルファリンナトリウムは,近親静脈血栓症における長期抗凝固薬の最も費用対効果の高い戦略です.
- 長期的なPVT管理に関する臨床的決定は,費用対効果を考慮する必要があります.
- 抗凝固剤療法における患者のケアを最適化するために,経済的評価は極めて重要です.
関連する概念動画
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...


